WHO vaccine-preventable diseases: monitoring system. 2014 global summary

Last updated 15-Jul-2014 (Data received as of 8-Jul-2014)
Next overall update Fall 2014
EPI mother and child logo         
Select a country

Development status: Developed economy GNI / capita (US$): 43'9301 Infant (under 12 months) mortality rate: 22
GDP / capita (US$): 39'9961 Child (under 5 years) mortality rate: 22

Population data in thousands3

  2013  2012  2011  2010  2009  2000  1990  1980 
Total population 330  326  322  318  314  281  255  228 
Births
Surviving infants
Pop. less than 5 years 24  24  24  23  23  21  21  21 
Pop. less than 15 years 68  68  67  67  66  65  64  63 
Female 15-49 years 78  78  78  78  77  72  65  56 

Number of reported case

(Click for retrospective incidence data for Iceland)
Diphtheria
Japanese encephalitis
Measles 14  13 
Mumps
Pertussis 31  36  41 
Polio*
Rubella
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total)
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Iceland)
Vaccine year result method % card seen                                                
BCG         
DTP1          97  97  99  98  99  99 
DTP3          91  89  95  96  96  98  99 
HepB_BD         
HepB3         
Hib3          91  89  95  96  98 
JapEnc         
MCV          91  90  94  93  92  91  99 
MCV2          94  97  90  93 
PCV1          96  96  89 
PCV3          89  86 
Pol3          91  89  95  96  98  99 
Rota1         
Rota_last         
Rubella1          91  90  94  92 
TT2plus          99 
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Iceland)
DTP1 97  97  99  98  99  99  99  99 
DTP3 91  89  95  96  96  98  99  99 
HepB3
HepB_BD
Hib3 91  89  95  96  96  98 
MCV 91  90  94  93  92  91  99 
MCV2 94  97  90  92  93 
PCV3 88  86 
Pol3 91  89  95  96  96  98  99  99 
Rota_last

Number of districts in the country 59  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
 
   
/
|
|
\
Greater or equal to 90% 0
From 80 to 89% 0
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
100
 

Immunization Schedule (2013 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
DTaPHibIPV 3, 5, 12 months; Yes
DTaPIPV 14 years; Yes
HepA Yes risk groups
HepAHepB Yes risk groups
HepB Yes risk groups
HPV 12 years; +2, +6 months; Yes
Influenza Yes risk groups
IPV Yes travellers
JapEnc Yes travellers
MenACWY Yes travellers
MenC_conj 6, 8 months; Yes
MMR 18 months; 12 years; Yes
Pneumo_conj 3, 5, 12 months; Yes
Pneumo_ps Yes risk groups
Rubella Yes women and risk groups
Tdap 4 years; Yes
TT Yes risk group
Typhoid Yes travellers
Varicella Yes risk groups

Immunizaton indicators

Indicator Expected answer 2013  2012  2011  2010  2009  2008  2007 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  NA  NA  No  Yes 
What years does the MYP cover? number              
Nº of districts with microplans that include activities to raise immunization coverage number 59  59  59         

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes       

System performance

Total Nº districts in country number 59  59  59  59  59  NA 
Nº districts with DTP3 coverage >=80% number 59  59  59 
% of districts with DTP3 coverage >=80% From 0 to 100% 100  100  100   
Nº districts with measles (MCV1) coverage >=95% number          
% of districts with MCV1 coverage >=95% From 0 to 100%        

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  No       
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Estimated percentage of routine vaccines funded by Government From 0 to 100% 100  100  100  100  100  100   

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.